Clinventive is the practice of W. Stetson Line. It began on the vendor side, building the tools: research and product leadership at Provenda BioMetrics and at EDC pioneer Phase Forward — including an early electronic clinical outcome assessment (eCOA) system featured in a Microsoft case study.
Then the sponsor side, running the data: clinical programming and data management leadership at Genentech (where a paper on surfacing data changes for quality management took a PharmaSUG Best Paper award) and BioMarin, followed by a decade building and leading CDISC consultancy and implementation teams at Amgen and Exelixis. Along the way: founding and leading the CDISC SDS Conformance Rules team, authoring the rule set that evolved into today's CDISC CORE — work recognized with CDISC's 2017 award for Outstanding Contributions to Standards Development.
Clinventive, LLC was formed in June 2010 to carry that experience into independent practice. Today it consults on standards, programming, and submissions — currently under contract to a clinical-stage sponsor — and builds Verdatic, whose self-correcting approach to simulated study data was selected for presentation at the 2026 CDISC Interchange.
“I spent thirty years doing this work by hand. Verdatic is what that experience looks like as software.” — W. Stetson Line, President, Clinventive LLC
Full history on LinkedIn · Start a conversation